Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2016

Open Access 01-12-2016 | Study protocol

Efficacy of brief behavioral counselling by allied health professionals to promote physical activity in people with peripheral arterial disease (BIPP): study protocol for a multi-center randomized controlled trial

Authors: Nicola W. Burton, Zanfina Ademi, Stuart Best, Maria A. Fiatarone Singh, Jason S. Jenkins, Kenny D. Lawson, Anthony S. Leicht, Yorgi Mavros, Yian Noble, Paul Norman, Richard Norman, Belinda J. Parmenter, Jenna Pinchbeck, Christopher M. Reid, Sophie E. Rowbotham, Lisan Yip, Jonathan Golledge

Published in: BMC Public Health | Issue 1/2016

Login to get access

Abstract

Background

Physical activity is recommended for people with peripheral arterial disease (PAD), and can improve walking capacity and quality of life; and reduce pain, requirement for surgery and cardiovascular events. This trial will assess the efficacy of a brief behavioral counselling intervention delivered by allied health professionals to improve physical activity in people with PAD.

Methods

This is a multi-center randomised controlled trial in four cities across Australia. Participants (N = 200) will be recruited from specialist vascular clinics, general practitioners and research databases and randomised to either the control or intervention group. Both groups will receive usual medical care, a written PAD management information sheet including advice to walk, and four individualised contacts from a protocol-trained allied health professional over 3 months (weeks 1, 2, 6, 12). The control group will receive four 15-min telephone calls with general discussion about PAD symptoms and health and wellbeing. The intervention group will receive behavioral counselling via two 1-h face-to-face sessions and two 15-min telephone calls. The counselling is based on the 5A framework and will promote interval walking for 3 × 40 min/week. Assessments will be conducted at baseline, and 4, 12 and 24 months by staff blinded to participant allocation. Objectively assessed outcomes include physical activity (primary), sedentary behavior, lower limb body function, walking capacity, cardiorespiratory fitness, event-based claudication index, vascular interventions, clinical events, cardiovascular function, circulating markers, and anthropometric measures. Self-reported outcomes include physical activity and sedentary behavior, walking ability, pain severity, and health-related quality of life. Data will be analysed using an intention-to-treat approach. An economic evaluation will assess whether embedding the intervention into routine care would likely be value for money. A cost-effectiveness analysis will estimate change in cost per change in activity indicators due to the intervention, and a cost-utility analysis will assess change in cost per quality-adjusted life year. A full uncertainty analysis will be undertaken, including a value of information analysis, to evaluate the economic case for further research.

Discussion

This trial will evaluate the efficacy and cost-effectiveness of a brief behavioral counselling intervention for a common cardiovascular disease with significant burden.

Trial registration

ACTRN 12614000592640 Australian New Zealand Clinical Trials Registry. Registration Date 4 June 2014.
Appendix
Available only for authorised users
Literature
1.
2.
Askew C, Parmenter B, Leicht A, Walker P, Golledge J. Exercise & Sports Science Australia (ESSA) position statement on exercise prescription for patients with peripheral arterial disease and intermittent claudication. J Sci Med Sport. 2013;17(6):623–9.CrossRefPubMed
3.
Oka R, Altman M, Giacomini J, Szuba A, Cooke J. Exercise patterns and cardiovascular fitness of patients with peripheral arterial disease. J Vasc Nurs. 2004;22(4):109–14.CrossRefPubMed
4.
Golomb B, Dang T, Criqui M. Peripheral arterial disease: morbidity and mortality implications. Circulation. 2006;114(7):688–99.CrossRefPubMed
5.
McDermott M, Sufit R, Nishida T, Guralnik J, Ferrucci L, Tian L, Liu K, Tan J, Pearce W, Schneider J, et al. Lower extremity nerve function in patients with lower extremity ischemia. Arch Intern Med. 2006;166(18):1986–92.CrossRefPubMedPubMedCentral
6.
7.
Mahoney E, Wang K, Keo H, Duval S, Smolderen K, Cohen D, Steg G, Bhatt D, Hirsch A, Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators. Vascular hospitalisation rates and costs in patients with peripheral artery disease in the United States. Circ Cardiovasc Qual Outcomes. 2010;3(6):642–51.CrossRefPubMed
8.
Long J, Modrall JG, Parker BJ, Swann A, Welborn MB 3rd, Anthony T. Correlation between ankle-brachial index, symptoms and health-related quality of life in patients with peripheral vascular disease. J Vasc Surg. 2004;39(4):723–7.
9.
Gardner A, Montgomery P, Killewich L. Natural history of physical function in older men with intermittant claudication. J Vasc Surg. 2004;40:70–8.CrossRef
10.
Regensteiner J, Hiatt W, Coll J, Criqui M, Treat-Jacobson D, McDermott M, Hirsch A. The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program. Vasc Med. 2008;13(1):15–24.CrossRefPubMed
11.
Smolderen KG, Hoeks SE, Pedersen SS, van Domburg RT, de Liefde II, Poldermans D. Lower-leg symptoms in peripheral arterial disease are associated with anxiety, depression, and anhedonia. Vasc Med. 2009;14(4):297–304.CrossRefPubMed
12.
Gardner A, Montgomery P, Parker D. Physical activity is a predictor of all-cause mortality in patients with intermittent claudication. J Vasc Surg. 2008;47(1):117–22.CrossRefPubMedPubMedCentral
13.
Grenon S, Vittinghoff E, Owens C, Conte M, Whooley M, Cohen B. Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study. Vasc Med. 2013;18(4):176–84.CrossRefPubMedPubMedCentral
14.
Ankle Brachial Index Collaboration, Fowkes F, Murray G, Butcher I, Heald C, Lee R, Chambless L, Folsom A, Hirsch A, Dramaix M, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300(2):197–208.CrossRefPubMedCentral
15.
Selvin E, Erlinger T. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000. Circulation. 2004;110:738–43.CrossRefPubMed
16.
Bergiers S, Vaes B, Degryse J. To screen or not to screen for peripheral arterial disease in subjects aged 80 and over in primary health care: a cross-sectional analysis from the BELFRAIL study. BMC Fam Pract. 2011;12:39.CrossRefPubMedPubMedCentral
17.
Hirsch A, Hartman L, Town R, Virnig B. National health care costs of peripheral arterial disease in the Medicare population. Vasc Med. 2008;13(3):209–15.CrossRefPubMed
18.
19.
Fowkes F, Leng G. Bypass surgery for chronic lower limb ischaemia. Cochrane Database Syst Rev. 2008;16(2):CD002000.
20.
Murphy T, Cutlip D, Regensteiner J, Mohler E, Cohen D, Reynolds M, Massaro J, Lewis B, Cerezo J, Oldenburg N, et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation. 2012;125(1):130–9.CrossRefPubMed
21.
Network SIG. Diagnosis and management of peripheral arterial disease. A national clinical guideline. Scotland: NHS Quality Improvement; 2006.
22.
Layden J, Michaels J, Bermingham S, Higgins B, on behalf of the the Guideline Development Group. Diagnosis and management of lower limb peripheral arterial disease: summary of NICE guidance. Br Med J. 2012;345:e4947.CrossRef
23.
Norgren L, Hiatt W, Dormandy JA, Nehler M, Harris K, Fowkes F, on behalf of the TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease. J Vasc Surg. 2007;45:S5–67.CrossRefPubMed
24.
European Stroke Organisation, Tendera M, Aboyans V, Bartelink M, Baumgartner I, Clément D, Collet J, Cremonesi A, De Carlo M, Erbel R, et al. ESC guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the task force on the diagnosis and treatment of peripheral artery diseases of the European society of cardiology (ESC). Eur Heart J. 2011;32(22):2851–906.CrossRef
25.
Gardner A, Poehlman E. Exercise rehabilitation programs for the treatment of claudication pain. A meta analysis. JAMA. 1995;274(12):975–80.CrossRefPubMed
26.
Nordanstig J, Gelin J, Hensäter M, Taft C, Österberg K, Jivegård L. Walking performane and health related quality of life after surgical or endovascular invasive versus non-invasive treatment for intermittent claudication-a prospective randomised trial. Eur J Vasc Endovasc Surg. 2011;42(2):220–7.CrossRefPubMed
27.
Mazari F, Kahn J, Carradice D, Samuel N, Abdul Rahman M, Gulati S, Lee H, Mehta T, McCollum P, Chetter I. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for itnermittant claudication due to femoropopliteal arterial disease. Br J Surg. 2012;99(1):39–48.CrossRefPubMed
28.
Vemulapalli S, Dolor R, Hasselblad V, Schmit K, Banks A, Heidenfelder B, Patel M, Jones W. Supervised vs unsupervised exercise for intermittent claudication: a systematic review and meta-analysis. Am Heart J. 2015;169(6):924–37.CrossRefPubMed
29.
Parmenter BD, Dieberg G, Smart NA. Exercise training for management of peripheral arterial disease: a systematic review and meta-analysis. Sports Med. 2015;45(2):231–44.CrossRefPubMed
30.
Lane R, Ellis B, Watson G, Leng G. Exercise for intermittant claudication. Cochrane Database Syst Rev. 2014;18(7):CD000990.
31.
32.
Crowther R, Spinks W, Leicht A, Sangla K, Quigley F, Golledge J. Effects of a long term exercise program on lower limb mobility, physiological responses, walking performance, and physical activity levels in patients with peripheral arterial disease. J Vasc Surg. 2008;47(2):303–9.CrossRefPubMed
33.
Garg P, Liu K, Tian L, Guralnik J, Ferrucci L, Criqui M, Tan J, McDermott M. Physical activity during daily life and functional decline in peripheral arterial disease. Circulation. 2009;119(2):251–60.CrossRefPubMed
34.
Garg P, Tian L, Criqui M, Liu K, Ferrucci L, Guralnik J, Tan J, McDermott M. Physical activity during daily life and mortality in patients with with peripheral arterial disease. Circulation. 2006;114:242–8.CrossRefPubMedPubMedCentral
35.
McDermott M, Liu K, Ferrucci L, Tian L, Guralnik J, Liao Y, Criqui M. Greater sedentary hours and slower walking speed outside the home predict faster declines in functioning and adverse calf muscle changes in peripheral arterial disease. J Am Coll Cardiol. 2011;57(23):2356–64.CrossRefPubMedPubMedCentral
36.
McDermott M, Ades P, Guralnik J, Dyer A, Ferrucci L, Liu K, Nelson M, Lloyd-Jones D, Van Horn L, Garside D, et al. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication – a randomized controlled trial. JAMA. 2009;301(2):165–74.CrossRefPubMedPubMedCentral
37.
Makris G, Lattimer C, Lavida A, Geroulakos G. Availability of supervised exercise programs and the role of structured home-based exercise in peripheral arterial disease. Eur J Vasc Endovasc Surg. 2012;44(6):569–75.CrossRefPubMed
38.
Kakkos S, Geroulakos G, Nicolaides A. Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial. Eur J Vasc Endovasc Surg. 2005;30(2):164–75.CrossRefPubMed
39.
Cheetham D, Burgess L, Ellis M, Williams A, Greenhalgh R, Davies A. Does supervised exercise offer adjuvant benefit over exercise advice alone for the treatment of intermittent claudication? A randomised trial. Eur J Vasc Endovasc Surg. 2004;27(1):17–23.CrossRefPubMed
40.
Gelin J, Jivegård L, Taft C, Karlsson J, Sullivan M, Dahllöf A, Sandström R, Arfvidsson B, Lundholm K. Treatment efficacy of intermittent claudication by surgical intervention, supervised physical exercise training compared to no treatment in unselected randomised patients: one year results of functional and physiological improvements. Eur J Vasc Endovasc Surg. 2001;22(2):107–13.CrossRefPubMed
41.
Regensteiner J. Exercise rehabilitation for the patients with intermittant claudication: a highly effective yet underutilised treatment. Cardiovasc Hematol Disord Drug Targets. 2004;4(3):233–9.CrossRef
42.
Falcone R, Hirsch A, Regensteiner J, Treat-Jacobson D, Williams M, Hiatt W, Stewart K. Peripheral arterial disease rehabilitation: a review. J Cardpulm Rehabil. 2003;23(3):170–5.CrossRef
43.
Cunningham M, Swanson V, Pappas E, OʼCarroll R, Holdsworth R. Illness beliefs and walking behavior after revascularization for intermittent claudication: a qualitative study. J Cardiopulm Rehabil Prev. 2014;34(3):195–201.CrossRefPubMed
44.
Cunningham M, Swanson V, Holdsworth R. Using a psychological model to investigate the relationship between illness beliefs and walking behaviour of patients with intermittent claudication. Br J Surg. 2010;97(S1):6.
45.
Rejeski W, Tian L, Liao Y, McDermott M. Social cognitive constructs and the promotion of phsyical activity in patients with peripheral artery disease. J Cardiopulm Rehabil Prev. 2008;28:65–72.CrossRefPubMed
46.
Gibson J, Kenrick M. Pain and powerlessness: the experience of living with peripheral arterial disease. J Adv Nurs. 1998;27:737–45.CrossRefPubMed
47.
Treat-Jacobson D, Halverson S, Ratchford A, Regensteiner J, Lindquist R, Hirsch A. A patient-derived perspective of health-related quality of life with peripheral arterial disease. J Nurs Scholarsh. 2002;34(1):55–60.CrossRefPubMed
48.
Lin J, O’Connor E, Evans C, Senger C, Rowland M, Groom H. Behavioral counseling to promote a healthy lifestyle in persons with cardiovascular risk factors: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2014;161(8):568–73.CrossRefPubMed
49.
Kivela K, Elo S, Kyngas H, Kaariainen M. The effects of health coaching on adult patients with chronic diseases: a systematic review. Patient Educ Couns. 2014;97(2):147–57.CrossRefPubMed
50.
McDermott M, Liu K, Guralnik J, Criqui M, Spring B, Tian L, Domanchuk K, Ferrucci L, Lloyd-Jones D, Kibbe M, et al. Home based walking exercise intervention in peripheral arterial disease: a randomised clinical trial. JAMA. 2013;310(1):57–65.CrossRefPubMed
51.
Rejeski W, Spring B, Domanchuk K, Tao HM, Tian L, Zhao LH, McDermott M. A group-mediated, home-based physical activity intervention for patients with peripheral artery disease: effects on social and psychological function. J Transl Med. 2014;12:29–29.
52.
McDermott M, Guralnik J, Criqui M, Ferrucci L, Zhao L, Liu K, Domanchuk K, Spring B, Tian L, Kibbe M, et al. Home-based walking exercise in peripheral artery disease: 12-month follow-up of the GOALS randomized trial. J Am Heart Assoc. 2014;3(3):e000711.CrossRefPubMedPubMedCentral
53.
Cunningham M, Swanson V, O’Caroll R, Holdsworth R. Randomized clinical trial of a brief psychological intervention to increase walking in patients with intermittent claudication. Br J Surg. 2012;99(1):49–56.CrossRefPubMed
54.
Cunningham M, Swanson V, Holdsworth R, O’Carroll R. Late effects of a brief psychological intervention with intermittent claudication in a randomized clinical trial. Br J Surg. 2013;100(6):756–60.CrossRefPubMed
55.
Goldstein M, Whitlock E, DePue J, Planning Committee of the Addressing Multiple Behavioral Risk Factors in Primary Care project. Multiple behavioral risk factor interventions in primary care: summary of research evidence. Am J Prev Med. 2004;27(2):61–79.CrossRefPubMed
56.
The Australian Clinical Trial Handbook. A simple, practical guide to the conduct of clinical trials to International standards of Good Clinical Practice (GCP) in the Australian context. Canberra: Commonwealth of Australia; 2006.
57.
Ryan C, Grant P, Tigbe W, Granat M. The validity and reliability of a novel activity monitor as a measure of walking. Br J Sports Med. 2006;40(9):779–84.CrossRefPubMedPubMedCentral
58.
PAL Technologies Ltd. ActivPAL3TM operating guide (PALaP3manual.2031.40525.1.3.docx). Glasgow; PAL Technologies Ltd.; 2010.
59.
Grant P, Ryan C, Tigbe W, Granat M. The validation of a novel activity monitor in the measurement of posture and motion during everyday activities. Br J Sports Med. 2006;40(12):992–7.CrossRefPubMedPubMedCentral
60.
Barreira T, Zderic T, Schuna JJ, Hamilton M, Tudor-Locke C. Free-living activity counts-derived breaks in sedentary time: are they real transitions from sitting to standing? Gait Posture. 2015;42(1):70–2.CrossRefPubMed
61.
Grant P, Dall P, Mitchell S, Granat M. Activity-monitor accuracy in measuring step number and cadence in community-dwelling older adults. J Aging Phys Act. 2008;16(2):201–4.CrossRefPubMed
62.
Clarke C, Holdsworth RJ, Ryan C, Granat M. Free-living physical activity as a novel outcome measure in patients with intermittent claudication. Eur J Vasc Endovasc Surg. 2013;45(2):162–7.CrossRefPubMed
63.
McDermott M, Ades P, Dyer AG JM, Kibbe M, Criqui M. Corridor based functional performance measures correlate better with physical activity during daily life than treadmill measures in persons with peripheral arterial disease. J Vasc Surg. 2008;48:1231–7.CrossRefPubMedPubMedCentral
64.
Bendermacher B, Willigendael E, Teijink J, Prins M. Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev. 2006;19(2):CD005263.
65.
van Asselt A, Nicolaï S, Joore M, Prins M, Teijink J, Exercise Therapy in Peripheral Arterial Disease Study Group. Cost-effectiveness of exercise therapy in patients with intermittent claudication: supervised exercise therapy versus a ‘go home and walk’ advice. Eur J Vasc Endovasc Surg. 2011;41(1):97–103.CrossRefPubMed
66.
Golledge J, Ewels C, Muller R, Walker P. Association of chronic kidney disease categories defined with different formulae with major adverse events in patients with peripheral vascular disease. Atherosclerosis. 2014;232(2):289–97.CrossRefPubMed
67.
Golledge J, Quigley F, Velu R, Walker P, Moxon J. Association of impaired fasting glucose, diabetes and their management with the presentation and outcome of peripheral artery disease: a cohort study. Cardiovasc Diabetol. 2014;13:147.CrossRefPubMedPubMedCentral
68.
Biros E, Gäbel G, Moran C, Schreurs C, Lindeman J, Walker P, Nataatmadja M, West M, Holdt L, Hinterseher I, et al. Differential gene expression in human abdominal aortic aneurysm and aortic occlusive disease. Oncotarget. 2015;6(15):12984–96.CrossRefPubMedPubMedCentral
69.
Biros E, Moran C, Wang Y, Walker P, Cardinal J, Golledge J. microRNA profiling in patients with abdominal aortic aneurysms: the significance of miR-155. Clin Sci. 2014;126(11):795–803.CrossRefPubMed
70.
Golledge J, Clancy F, Moran C, Biros E, Rush C, Walker P, Norman P. The novel association of the chemokine CCL22 with abdominal aortic aneurysm. Am J Pathol. 2010;176(5):2098–106.CrossRefPubMedPubMedCentral
71.
Golledge J, Muller R, Clancy P, McCann M, Norman P. Evaluation of the diagnostic and prognostic value of plasma D-dimer for abdominal aortic aneurysm. Eur Heart J. 2011;32(3):354–64.CrossRefPubMed
72.
Golledge J, Clancy P, Yeap B, Hankey G, Norman P. Increased serum angiopoietin-2 is associated with abdominal aortic aneurysm prevalence and cardiovascular mortality in older men. Int J Cardiol. 2013;167(4):1159–63.CrossRefPubMed
73.
Golledge J, Clancy P, Hankey G, Norman P. Relation between serum thrombospondin-2 and cardiovascular mortality in older men screened for abdominal aortic aneurysm. Am J Cardiol. 2013;111(12):1800–4.CrossRefPubMed
74.
Golledge J, Clancy P, Maguire J, Lincz L, Koblar S, McEvoy M, Attia J, Levi C, Sturm J, Almeida O, et al. Plasma angiopoietin-1 is lower after ischemic stroke and associated with major disability but not stroke incidence. Stroke. 2014;45(4):1064–8.CrossRefPubMed
75.
Morris D, Cunningham M, Ahimastos A, Kingwell B, Pappas E, Bourke M, Reid C, Stijnen T, Dalman R, Aalami O, et al. TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial. Trials. 2015;16:274.CrossRefPubMedPubMedCentral
76.
Golledge J, Cronin O, Iyer V, Bradshaw B, Moxon J, Cunningham M. Body mass index is inversely associated with mortality in patients with peripheral vascular disease. Atherosclerosis. 2013;229(2):549–55.CrossRefPubMed
77.
Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, et al. International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–96.CrossRefPubMed
78.
Harada N, Chiu V, King A, Stewart A. An evaluation of three self-report physical activity instruments for older adults. Med Sci Sport Exer. 2001;33:962–70.CrossRef
79.
Rengo G, Galasso G, Vitale D, Furgi G, Zincarelli C, Golino L, Femminella G, Piscione F, Rengo F, Leosco D. An active lifestyle prior to coronary surgery is associated with improved survival in elderly patients. J Gerontol A Biol Sci Med Sci. 2010;65(7):758–63.CrossRefPubMed
80.
Wijndaele K, De Bourdeaudhuij I, Godino J, Lynch B, Griffin S, Westgate K, Brage S. Reliability and validity of a domain-specific last-7-day sedentary time questionnaire. Med Sci Sports Exerc. 2014;46(6):1248–60.CrossRefPubMedPubMedCentral
81.
Sagar S, Brown P, Zelt D, Pickett W, Tranmer J. Further clinical validation of the walking impairment questionnaire for classification of walking performance in patients with peripheral artery disease. Int J Vasc Med. 2012;2012:Article ID 190641.
82.
Nicolaï SP, Kruidenier LM, Rouwet EV, Graffius K, Prins MH, Teijink JA. The walking impairment questionnaire: an effective tool to assess the effect of treatment in patients with intermittent claudication. J Vasc Surg. 2009;50(1):89–94.CrossRefPubMed
83.
Chong P, Garratt A, Golledge J, Greenhalgh R, Davies A. The Intermittent Claudication Questionnaire: a patient-assessed condition-specific health outcome measure. J Vasc Surg. 2002;36(4):764–71.CrossRefPubMed
84.
Treat-Jacobson D, Lindquist R, Witt D, Kirk L, Schorr E, Bronas U, Davey C, Regensteiner J. The PADQOL: Development and validation of a PAD-specific quality of life questionnaire. Vasc Med. 2012;17(6):405–15.CrossRefPubMed
85.
Leicht A, Crowther R, Muller R, Golledge J. The effects of including quality of life responses in models to predict walking performance of patients with intermittent claudication. Eur J Vasc Endovasc Surg. 2011;41(4):511–7.CrossRefPubMed
86.
Beattie D, Golledge J, Greenhalgh R, Davies A. Quality of life assessment in vascular disease: towards a consensus. Eur J Vasc Endovasc Surg. 1997;13(1):13.CrossRef
87.
Ware JJ, Kosinski M, Bjorner J, Turner-Bowker D, Gandek B, Maruish M. User’s Manual for the SF-36v2 Health Survey. 2nd ed. Lincoln, RI: QualityMetric Incorporated; 2007.
88.
Brazier J, Roberts J, Deverill M. The estimation of a preference-based index from the SF-36. J Health Econ. 2002;21:217–92.CrossRef
89.
Norman R, Cronin P, Viney R. A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states. Appl Health Econ Health Policy. 2013;11(3):287–98.CrossRefPubMed
90.
Norman R, Viney R, Brazier J, Burgess L, Cronin P, King M, Ratcliffe J, Street D. Valuing SF-6D health states using a discrete choice experiment. Med Decis Making. 2013;34(6):773–86.CrossRefPubMed
91.
Vos T, Carter R, Barendregt J, Mihalopoulos C, Veerman J, Magnus A, Cobiac L, Bertram M, Wallace A. ACE–Prevention Team: Assessing Cost-Effectiveness in Prevention (ACE–Prevention): Final Report. Brisbane and Deakin University, Melbourne: University of Queensland; 2010.
92.
Visconti A, Doyle J, Weir A, Shiell A, Hellard M. Assessing the cost-effectiveness of treating chronic hepatitis C virus in people who inject drugs in Australia. J Gastroenterol Hepatol. 2013;28(4):707–16.CrossRefPubMed
93.
Kessler R, Barber C, Beck A, Berglund P, Cleary P, McKenas D, Pronk N, Simon G, Stang P, Ustun T, et al. The World Health Organization Health and Work Performance Questionnaire (HPQ). J Occup Environ Med. 2003;45(2):156–74.CrossRefPubMed
94.
Briggs A, Weinstein M, Fenwick E, Karnon J, Sculpher M, Palteil AD, on behalf of the ISPOR-SMDM Modeling Good research Practices Task Force. Model parameter estimation and uncertainty analysis. A report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group–6. Med Decis Making. 2012;32(5):722–32.CrossRefPubMed
95.
Gardner A, Parker D, Montgomery P, Scott K, Blevins S. Efficacy of quantified home based exercise and supervised exercise in patients with intermittant claudication: a randomized controlled trial. Circulation. 2011;123:491–8.CrossRefPubMedPubMedCentral
96.
Al-Jundi W, Madbak K, Beard J, Nawaz S, Tew G. Systematic review of home-based exercise programmes for individuals with intermittent claudication. Eur J Vasc Endovasc Surg. 2013;46(6):690–706.CrossRefPubMed
Metadata
Title
Efficacy of brief behavioral counselling by allied health professionals to promote physical activity in people with peripheral arterial disease (BIPP): study protocol for a multi-center randomized controlled trial
Authors
Nicola W. Burton
Zanfina Ademi
Stuart Best
Maria A. Fiatarone Singh
Jason S. Jenkins
Kenny D. Lawson
Anthony S. Leicht
Yorgi Mavros
Yian Noble
Paul Norman
Richard Norman
Belinda J. Parmenter
Jenna Pinchbeck
Christopher M. Reid
Sophie E. Rowbotham
Lisan Yip
Jonathan Golledge
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2016
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-016-3801-7

Other articles of this Issue 1/2016

BMC Public Health 1/2016 Go to the issue

Research article

Intestinal polyparasitism with special emphasis to soil-transmitted helminths among residents around Gilgel Gibe Dam, Southwest Ethiopia: a community based survey

Research article

Type of sexual intercourse experience and suicidal ideation, plans, and attempts among youths: a cross-sectional study in South Korea

Research article

Associations between access to recreational physical activity facilities and body mass index in Scottish adults

Erratum

Erratum to: ‘The educational gradient of obesity increases among Swedish pregnant women: a register-based study’

Research article

Modelling the potential impact of a sugar-sweetened beverage tax on stroke mortality, costs and health-adjusted life years in South Africa

Research article

The effectiveness bundling of zinc with Oral Rehydration Salts (ORS) for improving adherence to acute watery diarrhea treatment in Ethiopia: cluster randomised controlled trial